93 related articles for article (PubMed ID: 1455369)
1. [The prediction of thrombosis development in patients with systemic lupus erythematosus: the role of antibodies to cardiolipin].
Nasonov EL; Kovalev VIu; Alekberova ZS; Solov'ev SK
Ter Arkh; 1992; 64(5):25-30. PubMed ID: 1455369
[TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
3. [The clinico-immunological characteristics of central nervous system involvement in systemic lupus erythematosus: the relationship with antibodies to cardiolipin].
Travkina IV; Ivanova MM; Nasonov EL; Shmidt TE; Kovalev VIu
Ter Arkh; 1992; 64(5):10-4. PubMed ID: 1455360
[TBL] [Abstract][Full Text] [Related]
4. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
5. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
7. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
9. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
11. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
12. Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome.
Guglielmone HA; Fernandez EJ
J Rheumatol; 1999 Jan; 26(1):86-90. PubMed ID: 9918246
[TBL] [Abstract][Full Text] [Related]
13. [Anticardiolipin antibodies in patients with systemic lupus erythematosus].
Petrović R; Petrović M; Novicić-Sasić D; Damjanov N
Srp Arh Celok Lek; 1994; 122 Suppl 1():98-100. PubMed ID: 18173204
[TBL] [Abstract][Full Text] [Related]
14. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
[TBL] [Abstract][Full Text] [Related]
15. [Anticardiolipin antibodies in diffuse connective tissue diseases with IgG, IgM and IgA isotypes].
Hrncír Z; Chýlková V
Vnitr Lek; 1990 Nov; 36(11):1041-9. PubMed ID: 2267732
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Delgado Alves J; Kumar S; Isenberg DA
Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
[TBL] [Abstract][Full Text] [Related]
17. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus.
Molina JF; Gutierrez-Ureña S; Molina J; Uribe O; Richards S; De Ceulaer C; Garcia C; Wilson WA; Gharavi AE; Espinoza LR
J Rheumatol; 1997 Feb; 24(2):291-6. PubMed ID: 9034985
[TBL] [Abstract][Full Text] [Related]
18. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
20. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
